Dallas, TX -- (SBWIRE) -- 10/06/2014 -- “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Israel”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Israel’s population stood at approximately 8.1 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 2.0% from 2008. Well-defined and detailed regulatory filling procedures, separate departments for the assessment of quality and safety of pharmaceutical products, and ease of access all benefit pharmaceutical players. R&D expenditure in the field of science and technology and technological advancements in healthcare are the distinguishing features of the Israeli pharmaceutical market. Gross Domestic Product (GDP) expenditure on R&D was an estimated $9.12 billion in 2013.

Complete Report Details
http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-israel-market-report.html

The pharmaceutical market was worth approximately $1.9 billion in 2013, and the Israeli pharmaceutical industry has more than 76 companies, of which 22% are involved in drug discovery and 17% in drug delivery. The pharmaceutical market is set to grow at a CAGR of 2.8% from 2008 to reach $2.3 billion in 2020. The medical device market was worth approximately $1.3 billion in 2013 and is expected to grow to approximately $1.8 billion by 2020 at a CAGR of 5.0%.

These positive growth trends can be primarily attributed to:

-An increasingly elderly population
-Universal healthcare coverage
-Government initiatives

Scope:

The report provides information on the Israeli healthcare, regulatory and reimbursement landscape and includes:

-An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

-Profiles and SWOT analyses of the major players in the pharmaceutical market (Teva, Taro Pharma, Dexcel Pharma, and Rekah Pharmaceutical) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, B. Braun, Siemens Healthcare, Boston Scientific and Roche)

-An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

-Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

-An overview of the opportunities for and challenges to growth in the healthcare market

Order a Purchase copy
http://www.rnrmarketresearch.com/contacts/purchase?rname=217358

Reasons to buy:

This report will enhance your decision-making capability by allowing you to:

-Develop business strategies by understanding the trends shaping and driving Israel’s healthcare market

-Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Israel’s healthcare market in the future

-Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

-Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

-Identify, understand, and capitalize on the opportunities and challenges in Israel’s healthcare market

Table of Contents

1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12

2 Introduction 16
2.1 GlobalData Report Guidance 16

3 Overview of the Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 20
3.1.3 Supply Channels 22
3.1.4 Market Segments 22
3.1.5 Overview of Top Five Disease Areas 24
3.1.6 Major Players 26
3.2 Medical Device Market 50
3.2.1 Market Overview 50
3.2.2 Overview of Top Five Segments 52
3.2.3 Diagnostic Market 66
3.2.4 Major Players 68
3.3 Market Drivers and Barriers 102
3.3.1 Drivers 102
3.3.2 Barriers 103

4 Market Access 105
4.1 Reimbursement and Payer Landscape 105
4.1.1 Overview of Healthcare System 105
4.1.2 Reimbursement Process 106
4.1.3 Overview of Insurance Providers 107
4.1.4 Patient Share in Healthcare Spending 113
4.1.5 Price Trend in Healthcare Services 115
4.1.6 Pricing Policies 116
4.2 Regulatory Landscape 116
4.2.1 Overview of Regulatory Agencies 116
4.2.2 Market Authorization Procedure for Pharmaceutical Products 119
4.2.3 Market Authorization Procedure for Medical Devices 121
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 122
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 123
4.2.6 Intellectual Property Rights 125
4.2.7 Clinical Trial Regulations 128
4.2.8 Pharmaceutical Advertising Regulations 130
4.2.9 Pharmacy Regulations 131
4.2.10 Labeling and Packaging Regulations 132

5 Country Analysis 133
5.1 Political Environment 133
5.1.1 Political Structure 133
5.1.2 Analysis of the Current Political Environment 134
5.1.3 Healthcare Policy Initiatives 137
5.2 Economic Landscape 137
5.3 Economic Indicators 139
5.3.1 Gross Domestic Product 139
5.3.2 Gross National Income 143
5.3.3 Inflation 144
5.3.4 Currency Exchange Rate 148
5.3.5 Foreign Direct Investment 149
5.3.6 Foreign Exchange Reserves 150
5.3.7 Trade Balance 151
5.3.8 General Government Structural Balance 153
5.3.9 General Government Net Debt 154
5.3.10 Major Industries 157
5.4 Demographics 158
5.4.1 Population 158
5.4.2 Education and Literacy 179
5.4.3 Employment 182
5.4.4 Disease Burden 184
5.5 Healthcare Infrastructure 187
5.5.1 Healthcare Facilities 187
5.5.2 Healthcare Parameters 192
5.5.3 Environmental Health 195
5.5.4 Healthcare Personnel 199
5.6 Healthcare Expenditure 202
5.6.1 Overview 202
5.6.2 Public and Private Sector Share 203
5.6.3 Major Components of Healthcare Spending 205
5.6.4 Healthcare Expenditure by Financing Agent 206
5.6.5 Spending in Science and Technology Research and Development 207
5.7 Trade Associations 209
5.7.1 Pharmaceutical Association of Israel 209
5.7.2 Pharma Israel 209
5.8 Trade Fairs 210

6 Opportunities and Challenges 211
6.1 Opportunities 211
6.2 Challenges 212

7 Appendix 214
7.1 Abbreviations 214
7.2 Bibliography 218
7.3 Research Methodology 231
7.3.1 Coverage 231
7.3.2 Secondary Research 232
7.3.3 Forecasts 232
7.3.4 Expert Panel 232
7.4 Disclaimer 233

Browse more reports on Healthcare Market
http://www.rnrmarketresearch.com/reports/life-sciences/healthcare